Phase 2 Study: A Double-blind, Randomised, Clinical Cross-over Trial to Investigate the Treatment Potential of Liraglutide Compared to Glimepiride in MODY Patients [Effekten af GLP-1 i maturity onset diabetes of the young (MODY)]

Trial Profile

Phase 2 Study: A Double-blind, Randomised, Clinical Cross-over Trial to Investigate the Treatment Potential of Liraglutide Compared to Glimepiride in MODY Patients [Effekten af GLP-1 i maturity onset diabetes of the young (MODY)]

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2013

At a glance

  • Drugs Liraglutide (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms MODY
  • Most Recent Events

    • 23 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 14 Jan 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 11 Aug 2012 Actual initiation date (3 Aug 2012) added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top